Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124025402 | 12402540 | 2 | F | 20130203 | 20160824 | 20160525 | 20160901 | EXP | DK-DKMA-ADR 23479728 | DK-PFIZER INC-2016265237 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160901 | LW | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124025402 | 12402540 | 1 | PS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 100 MG AT EVERY TREATMENT | U | 50467 | 100 | MG | |||||||
| 124025402 | 12402540 | 2 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG AT EVERY TREATMENT. STRENGHT: 1 MG/ML. | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124025402 | 12402540 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 800 MG AT EVERY TREATMENT | U | 0 | 800 | MG | |||||||
| 124025402 | 12402540 | 4 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1500 MG AT EVERY TREATMENT | U | 0 | 1500 | MG | |||||||
| 124025402 | 12402540 | 5 | C | VICTOZA | LIRAGLUTIDE | 1 | 1 DF, UNK | 0 | 1 | DF | |||||||||
| 124025402 | 12402540 | 6 | C | MAREVAN | WARFARIN SODIUM | 1 | 25 MG, 10 PER WEEK | 0 | 25 | MG | /wk | ||||||||
| 124025402 | 12402540 | 7 | C | DICLON | DICLOFENAC SODIUM | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 124025402 | 12402540 | 8 | C | PINEX | ACETAMINOPHEN | 1 | 500 MG X 6 | 0 | 500 | MG | |||||||||
| 124025402 | 12402540 | 9 | C | HJERTEMAGNYL | ASPIRINMAGNESIUM OXIDE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 124025402 | 12402540 | 10 | C | ACICLOVIR | ACYCLOVIR | 1 | UNK | 0 | |||||||||||
| 124025402 | 12402540 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 124025402 | 12402540 | 12 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 3 MG, 1X/DAY | 0 | 3 | MG | QD | ||||||||
| 124025402 | 12402540 | 13 | C | CODEINE | CODEINE | 1 | 25 MG, 4X/DAY | 0 | 25 | MG | QID | ||||||||
| 124025402 | 12402540 | 14 | C | IBUPROFEN. | IBUPROFEN | 1 | 400 MG, 3X/DAY | 0 | 400 | MG | TID | ||||||||
| 124025402 | 12402540 | 15 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124025402 | 12402540 | 1 | Follicle centre lymphoma, follicular grade I, II, III |
| 124025402 | 12402540 | 2 | Follicle centre lymphoma, follicular grade I, II, III |
| 124025402 | 12402540 | 3 | Follicle centre lymphoma, follicular grade I, II, III |
| 124025402 | 12402540 | 4 | Follicle centre lymphoma, follicular grade I, II, III |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124025402 | 12402540 | OT |
| 124025402 | 12402540 | HO |
| 124025402 | 12402540 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124025402 | 12402540 | Ascites | |
| 124025402 | 12402540 | Asthenia | |
| 124025402 | 12402540 | Basal cell carcinoma | |
| 124025402 | 12402540 | Cardiac failure | |
| 124025402 | 12402540 | Cardiomegaly | |
| 124025402 | 12402540 | Decreased appetite | |
| 124025402 | 12402540 | Disease progression | |
| 124025402 | 12402540 | Dyspnoea | |
| 124025402 | 12402540 | Ejection fraction decreased | |
| 124025402 | 12402540 | Fatigue | |
| 124025402 | 12402540 | Feeling of body temperature change | |
| 124025402 | 12402540 | Follicle centre lymphoma, follicular grade I, II, III | |
| 124025402 | 12402540 | Hallucination | |
| 124025402 | 12402540 | Oedema peripheral | |
| 124025402 | 12402540 | Pleural effusion | |
| 124025402 | 12402540 | Pneumonia | |
| 124025402 | 12402540 | Pyrexia | |
| 124025402 | 12402540 | Second primary malignancy | |
| 124025402 | 12402540 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124025402 | 12402540 | 1 | 20121012 | 20130125 | 0 | |
| 124025402 | 12402540 | 2 | 20121012 | 20130125 | 0 | |
| 124025402 | 12402540 | 3 | 20121012 | 20130429 | 0 | |
| 124025402 | 12402540 | 4 | 20121012 | 20130125 | 0 |